Skip to main content

Aimovig News

Erenumab Effective, Safe for Rosacea-Linked Erythema, Flushing

WEDNESDAY, April 17, 2024 – The anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according...

FDA Approves Aimovig (erenumab-aooe) as a Preventive Treatment for Migraine

May 17, 2018 – The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Migraine Prevention, Migraine Prophylaxis

Aimovig patient information at Drugs.com